glp-1 gip therapy effectiveness muscle loss Frontiers Muscle loss and GLP-1R agonists

Diabetes Care (2015) 38(2):26470

Given that the first published case report appeared only recently, and that epidemiological studies are still emerging, a label update may follow as more data accumulates

Following the FDA-approved titration schedules for each specific GLP-1 medication is important

It usually takes approximately 5 months for patients to progress from a low dose of .25 milligrams to the target dose of 2.4 milligrams

In other words, posts criticizing GLP-1 medications were more likely to be shared, commented on, or debated , highlighting how a relatively small group of voices can exert a disproportionate influence on public perception